{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Colesevelam+hydrochloride", "query": { "intervention": "Colesevelam hydrochloride" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 36, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Colesevelam+hydrochloride&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-15T22:52:39.492Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00755352", "title": "A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Pravastatin for at Least 4 Weeks.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "pravastatin tablets and Welchol tablets", "type": "DRUG" }, { "name": "pravastatin tablets and Welchol placebo tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 67, "start_date": "2002-11", "completion_date": "2005-04", "has_results": false, "last_update_posted_date": "2015-04-03", "last_synced_at": "2026-09-15T22:52:39.492Z", "location_count": 15, "location_summary": "Los Angeles, California • Castle Rock, Colorado • Jacksonville, Florida + 12 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Castle Rock", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Pembroke Pines", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00755352" }, { "nct_id": "NCT00715273", "title": "Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Coronary Artery Disease", "Carotid Artery Diseases", "Atherosclerosis" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Niacin", "type": "DRUG" }, { "name": "Colesevelam", "type": "DRUG" }, { "name": "Placebo Niacin", "type": "DRUG" }, { "name": "Placebo Colesevelam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 217, "start_date": "2001-05-01", "completion_date": "2019-03-01", "has_results": true, "last_update_posted_date": "2022-06-07", "last_synced_at": "2026-09-15T22:52:39.492Z", "location_count": 4, "location_summary": "Los Angeles, California • Boise, Idaho • Seattle, Washington + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Boise", "state": "Idaho" }, { "city": "Seattle", "state": "Washington" }, { "city": "Yakima", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00715273" }, { "nct_id": "NCT01258075", "title": "Colesevelam for Children With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "High-dose colesevelam", "type": "DRUG" }, { "name": "Low-dose colesevelam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 236, "start_date": "2011-02-24", "completion_date": "2020-04-21", "has_results": true, "last_update_posted_date": "2021-05-13", "last_synced_at": "2026-09-15T22:52:39.492Z", "location_count": 24, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Los Angeles, California + 20 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01258075" }, { "nct_id": "NCT00476710", "title": "Effects of Colesevelam HCl On Bile Acid Kinetics", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Type 2 Diabetes Mellitus", "Impaired Glucose Tolerance" ], "interventions": [ { "name": "Colesevelam HCl", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "KineMed", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "40 Years to 60 Years" }, "enrollment_count": 36, "start_date": "2007-05", "completion_date": "2009-04", "has_results": false, "last_update_posted_date": "2015-04-01", "last_synced_at": "2026-09-15T22:52:39.492Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00476710" }, { "nct_id": "NCT01122108", "title": "Comparison of Colesevelam Hydrogen Chloride (HCl) Powder For Oral Suspension Versus Generic Cholestyramine Through Use of the Bile Acid Sequestrant Acceptability (BASA) Scale", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Cholestyramine", "type": "DRUG" }, { "name": "Colesevelam HCl", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Louisville Metabolic and Atherosclerosis Research Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 42, "start_date": "2010-04", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2010-10-07", "last_synced_at": "2026-09-15T22:52:39.492Z", "location_count": 1, "location_summary": "Louisville, Kentucky", "locations": [ { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01122108" }, { "nct_id": "NCT00789750", "title": "Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Colesevelam", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Pioglitazone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 562, "start_date": "2009-04", "completion_date": "2012-07", "has_results": true, "last_update_posted_date": "2017-06-26", "last_synced_at": "2026-09-15T22:52:39.492Z", "location_count": 141, "location_summary": "Birmingham, Alabama • Montgomery, Alabama • Green Valley, Arizona + 114 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00789750" }, { "nct_id": "NCT00951899", "title": "The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Colesevelam", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Diet", "type": "BEHAVIORAL" }, { "name": "Metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER", "BEHAVIORAL" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "35 Years to 70 Years" }, "enrollment_count": 38, "start_date": "2009-08", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2013-11-11", "last_synced_at": "2026-09-15T22:52:39.492Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00951899" }, { "nct_id": "NCT07226440", "title": "Examining a Novel Gastrointestinal Intervention to Negate Environmental Toxicants (ENGINE)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Toxicant Exposure", "Firefighter", "Occupational Exposure to Chemicals" ], "interventions": [ { "name": "Colesevelam", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 50, "start_date": "2026-03-01", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-04-24", "last_synced_at": "2026-09-15T22:52:39.492Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07226440" }, { "nct_id": "NCT00151762", "title": "Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Colesevelam hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 780, "start_date": "2004-12", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2008-01-09", "last_synced_at": "2026-09-15T22:52:39.492Z", "location_count": 62, "location_summary": "Birmingham, Alabama • Tuscumbia, Alabama • Jonesboro, Arkansas + 59 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscumbia", "state": "Alabama" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Searcy", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00151762" }, { "nct_id": "NCT03270085", "title": "Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Diarrhea", "Irritable Bowel Syndrome With Diarrhea", "Bile Acid Malabsorption" ], "interventions": [ { "name": "Colesevelam", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 30, "start_date": "2017-12-07", "completion_date": "2019-05-31", "has_results": true, "last_update_posted_date": "2020-04-27", "last_synced_at": "2026-09-15T22:52:39.492Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03270085" } ] }